Annals of the ICRP
Volume 32, Issue 1 , Pages 307-312, March 2002

ERRATA FOR PUBLICATIONS 66, 68, 69, 71, 72, and 78

Article Outline

 

ICRP Publication 66

PageItemCorrection
xGlossary: Inhalability and Regional deposition‘DϵI' should be ‘DEI'
xiGlossary: Aerosol parameters: AMADThe phrase ‘in the aerosol is associated with particles' is missing after ‘(aerodynamically classified)'. (Compare definition of AMTD.)
25Table 9, Japan section‘VLC' should be ‘VC'
35Table 10The assigned fraction for ET2 should be ‘0.998' not ‘1' as given
37Paragraph 126, line 5‘mode' should be ‘model'
41 Replace equation 5, paragraph 143 and equation 6 with the following:
Equation 5
Paragraph 143Defining ξjas the quotient σj/σj-1, then σj can be replaced by
Thus, the expression for DEj becomes:
Equation 6
43Paragraph 154, line 1‘on dae of the airborne particles' should be ‘on the dae of the airborne particles'
line 3/4Replace ‘The following expression represents particle inhalability:' with ‘The following expression represents particle inhalability averaged over 360o orientation to the wind direction:'
line 5Replace ‘(for D⩽U⩽10 m s–1)' with ‘(for 0⩽U⩽10 m s–1)
54Fig. 15 right-hand graph (range 0.1 – 100 μm)x-axis label should be ‘AMAD, μm' not ‘AMTD, μm'
PageItemCorrection
69Table 17, captionInsert ‘the' before ‘human'
76Paragraph 269, line 18Insert ‘and' between ‘occupational' and ‘environmental'
105Table 24‘BB basal' should be ‘BBbas' ‘BB secretory' should be ‘BBsec'
105Table 24The assigned fraction for ET2 should be ‘0.998' not ‘1' as given
105Table 24The mass of BB-secretory should be ‘0.00086' kg (not 0.00087 as given, see Table 5, page 21). Equivalent doses from sources BB1, BB2 and BBseq should be 1.67 x 10-6, 6.24 x 10-5 and 1.06 x 10-6 respectively, giving a total of 6.51 x 10-5 Sv. The mass of bb should be ‘0.0019' kg (not 0.002 as given, see Table 5, page 21). Equivalent doses from sources bb1, bb2, bbseq, and AI should be 4.68 x 10-6, 2.60 x 10-5, 6.34 x 10-7 and 2.85 x 10-6 respectively, giving a total of 3.41 x 10-5 Sv. The Weighted equivalent doses to BB-secretory and bb are both unchanged at 1.1 x 10-5 Sv, but that to the Total lungs should be 4.7 x 10-5 Sv.
109Table 26Footnote ‘a' missing from title
110Table 28, Footnote bChange ‘Table 16B' to ‘Table 8'
114Table 31The assigned fraction for ET2 should be ‘0.998' not ‘1' as given
144Paragraph A56, line 7Delete ‘mm' after ‘2.6 – 1.2'
175Paragraph B31‘height, (in m)' should be ‘height, H (in m)'
179Table B3, line TLC column 2 (Japan)‘Male: 3.4 m' should be ‘Male 3.4 H' ‘Female: 2.51 m' should be ‘Female: 2.51 H'
182Second bulletInsert ‘an' between ‘by' and ‘exponential'
197Table B16B, footnote d‘Section B.76' should be ‘Paragraph B.76'
239aParagraph D24λ = 0.0712 μm' should be ‘λ = 0.0683 μm'
239aParagraph D25The value of μ, the dynamic viscosity of air, should be 1.88 x 10-4 Poise not 1.90 x 10-4 Poise as given
241Paragraph D32Paragraph number repeated. In the first paragraph D32, line 1: ‘Eqn. D10' should be ‘Eqn. D11'; line 3: Eqns. D7 and D11 should be Eqn. D7
PageItemCorrection
243aFig. D4The caption is correct, but the Figure shown is actually Fig. D5
244aFig. D5The caption is correct, but the Figure shown is actually Fig. D4
297Rudolf et al. (1994)The word ‘airway' should be ‘aerosol' ‘Ann Occup Hyg' should be ‘Ann Occup Hyg 38 Suppl. 1 1–14'
297Schiller-Scotland et al. (1994)‘Ann Occup Hyg' should be ‘Ann Occup Hyg 38 Suppl. 1 117–125'
298Swift et al. (1994)‘Ann Occup Hyg' should be ‘Ann Occup Hyg 38 Suppl. 1 1 77–81'
299Yu and Cohen (1994)‘Ann Occup Hyg' should be ‘Ann Occup Hyg 38 Suppl. 1 83–89'
335E97The first phrase ‘Posterior nasal passage, oral passage, pharynx and larynx (ET2).' is a sub-heading and should be in italics. (Compare E96.)
354Paragraph E159, line 5‘about 0.5 at dae = 6 μm' should be ‘about 0.25 at dae = 6 μm'
405Patrick and Stirling (1994)Ann. Occup. Hyg.' should be ‘Ann. Occup. Hyg.38 Suppl. 1, 225-234'.
407Roth et al. (1994)Ann. Occup. Hyg.' should be ‘Ann. Occup. Hyg.38 Suppl. 1, 101-106'.
408Scheuch and Stalhofen (1994)Ann. Occup. Hyg.' should be ‘Ann. Occup. Hyg.38 Suppl. 1, 159-166'.
410Stahlhofen et al. (1994)189' should be ‘38 Suppl. 1, 189-196'.
410Stather et al. (1976)‘C-DTPA' should be ‘Ca-DTPA'.
412Vastag et al. (1985)‘(Suppl. 139)' should be ‘66 (Suppl. 139)'
416-432Tables F1 to F6 column 1Insert subheading ‘AMAD (μm)' between rows ‘0.2' and ‘0.5'
418-432Tables F3 to F6Row ‘1 μm' should be bold font. Row ‘5 μm' should be normal font.
aGiven in the errata for ICRP Publication 66 published in ICRP Publication 71
ICRP Publication 68
PageItemCorrection
77Table D.1 heading‘Class SR-D' should be ‘Class SR-0’
ICRP Publication 69
PageItemCorrection
18Table 1.-1f1 value for adult should be ‘0.1’ (not 0.2)
ICRP Publication 71
PageItemCorrection
39Section 5.1, Table 5.1.2(f)Insert footnote (a) on title: ‘These dose coefficients are based on the fraction of inhaled tritium gas absorbed into the blood (0.01%). Irradiation from gas within the lungs might increase lung doses by about a factor of three, and effective doses by about 20%'. A footnote (a) to this effect is given in the corresponding table in ICRP Publication 68 (Table C1 of Annex C).
370Table A.1The transfer rate from trabecular surface to exchangeable trabecular volume (‘Trab. surf. to exch. trab. vol.' in the adult should be changed from ‘8.000E-04’ to ‘1.160E-01’.
372Paragraph A17In the last line, ‘ST1’ should be ‘ST2’.
ICRP Publication 72
PageItemCorrection
6&7Table 2Footnotes c and d are wrongly placed. Footnote c (‘Also for ingestion dose coefficients') should be attached to the heading of Column 4, not Column 3. (On Page 7, the footnote reference should be ‘c' not ‘cc', and again it should be attached to the heading of Column 4, not Column 3). Footnote d (‘Tritium gas…') is correctly attached to Column 3, Row ‘Hydrogen', but it should not be attached to the heading of Column 4. In the heading of Column 4 ‘ICRP for' should be ICRP Publication for'. (All are corrected here in Table A17).
84Annex A, Table A.3Insert footnote (b) on Elemental hydrogen: ‘These doses are based on the fraction of inhaled tritium gas absorbed into the blood (0.01%). Irradiation from gas within the lungs might increase effective doses by about 20%'.
ICRP Publication 78
bFig. A.9.29.
PageItemCorrection
39Table A1.4Inhalation dose coefficient for tritium gas should be 1.8E-15 instead of 1.8E-14

40Table A1.10Table A1.10 is wrongly placed. It should immediately follow the paragraph ‘Hydrogen-3 Chronic intakes' and come before the heading ‘A.2 Iron'

41Fig. A.1.1.Fig. A.1.1. is wrongly placed. It should immediately follow Table A1.10.

42Fig. A.1.2.Figure A.1.2. is wrongly placed. It should immediately follow Fig. A1.1.

44Fig. A.2.1.Figure A.2.1. is wrongly placed. It should immediately follow the paragraph ‘A.2. Iron Biokinetic model' (Page 40).

45Figs. A.2.2, A.2.3, A.2.4, A.2.5Figs. A2.2, A.2.3, A.2.4. and A.2.5 are wrongly placed. They should follow on after Table A.2.9 and come before the heading ‘A.3. Cobalt'

109Table A.9.15In the columns 212Pb–Lungs and 208Tl–Lungs the first value should be without bracketsa, and the other values should be with bracketsa.

109Table A916.Caption ‘Table A916’ should be ‘Table A.9.16’. In the columns 212Pb–Lungs and 208Tl–Lungs all values should be in bracketsa

113Table A.9.26In the column Type M–Lungs all values should be in bracketsa. In the column Type M–Whole body the values for monitoring intervals 360d – 60d should be in bracketsa. In the column Type S–Lungs all values should be in bracketsa. In the column Type S–Whole body the values for monitoring intervals 360d – 60d should be in bracketsa.

117Fig. A.9.11 CaptionShould be ‘228Th Injection: predicted values (Bq per Bq intake) of 212Pb following acute intake of 228Th.'

118Fig. A.9.15 and A.9.16The two figures should be exchanged

123Fig. A.9.29Replace with figure belowb

144Fig. A.12.6Replace with figure belowc
aParagraph 91 of Publication 78 outlined the criterion used to decide whether a particular monitoring interval was suitable for use. In short, an interval was taken to be acceptable if an intake occurring on any day of the interval would not lead to an underestimate in a dose assessment of more than a factor of three compared with an intake occurring at the mid-point of the interval. In the vast majority of cases underestimates result from intakes occurring in the first half of the interval, i.e. before the mid-point. Thus attention was focused on this half of the interval during the selection of appropriate intervals for Publication 78. Intakes occurring late in the interval would generally be expected to lead to overestimates in dose assessments, and this was noted in Paragraph 91. However, for monitoring regimes based on decay products, underestimates can be caused by intakes occurring late in the monitoring interval since there may have been little ingrowth of the decay product when measurements are made. This was not properly accounted for in the selection of appropriate intervals in cases where monitoring is based on measurements of decay products. The errata above correct this oversight.

PII: S0146-6453(02)00027-1

doi:10.1016/S0146-6453(02)00027-1

Refers to article:

  • Preface

    Jack Valentin
    Annals of the ICRP January 2000 (Vol. 30, Issue 1, Pages vii-viii)

Annals of the ICRP
Volume 32, Issue 1 , Pages 307-312, March 2002